2026 San Diego 3-Day Raises $5.3 Million for Breast Cancer
It was an unforgettable weekend in San Diego as 1,700 participants united at the Susan G. Komen 3-Day® and transformed the city into a celebration of courage, determination and hope.
It was an unforgettable weekend in San Diego as 1,700 participants united at the Susan G. Komen 3-Day® and transformed the city into a celebration of courage, determination and hope.
Kristen Dugan worked hard to rebuild her life after breast cancer treatment when a triple negative breast cancer (TNBC) recurrence changed everything. As she returned to treatment, Kristen remained determined to continue training to run the TCS New York City Marathon with Team Komen while serving as the chair of the 2027 Komen West Palm Beach MORE THAN PINK Walk.
We’ve seen remarkable progress in treating hormone receptor-positive (HR+) metastatic breast cancer (MBC), with numerous new targeted therapies becoming available in recent years. But the work isn’t over yet. In this episode of Breast Cancer Breakthroughs, we are joined by MBC patient advocate Bethany Adair; Komen grantee and medical oncologist Sonya Reid, M.D.; and medical […]
The recent FDA approval stemming from the SERENA-6 clinical trial may usher in a new era in metastatic breast cancer (MBC) care. Evidence from the trial showed how a simple blood test using circulating tumor DNA (ctDNA) can help doctors guide treatment decisions for metastatic breast cancer (MBC). ctDNA testing can detect molecular changes in […]
For Wynter, life is measured in moments. Time spent with family, days on the water fishing, opportunities to travel and ordinary experiences that have taken on new meaning since her breast cancer diagnosis. Diagnosed with triple positive breast cancer in 2022 at age 41, Wynter is now living with stage 4 metastatic breast cancer (MBC). […]
Over the last few decades, more lives have been saved from breast cancer, thanks to early detection and increasingly personalized and innovative treatments. These advances contributed to a 44% decline in the breast cancer death rate in the U.S. between 1989 and 2024. Future progress that impacts real lives depends on breakthroughs in research, driven […]
In just a few days, the 2026 Susan G. Komen San Diego 3-Day® will be underway. Get ready for an unforgettable weekend filled with inspiration, the Pink Bubble community you know and love and a few new experiences along the way.
The 2026 Susan G. Komen Dallas/Forth Worth 3-Day® delivered an unforgettable weekend of impact. The event brough together 720 walkers and crew members who raised $1.9 million to support breast cancer research, community health, patient care and advocacy.
At the European Society for Medical Oncology (ESMO) Congress 2026, experts addressed five outstanding questions in breast cancer research, paving the ever-growing path to more personalized care. Last year’s ESMO Congress delivered a wave of phase 3 clinical trial results, and this year thousands of experts gathered in Madrid with more answers from many of […]
At the 2026 Susan G. Komen Dallas/Fort Worth 3-Day®, Glen D. was honored with the Milestone Award, recognizing his extraordinary contributions to the Pink Bubble community.
Mammography is the most effective screening test used today to find breast cancer in most women. Regular screening mammography (along with follow-up tests and treatment, if diagnosed) reduces the chance of dying from breast cancer. Below, we’re debunking seven of the most common mammogram myths, so you have the facts you need to make informed screening […]
At last week’s Susan G. Komen Dallas/Fort Worth 3-Day®, Fee P. was honored with the Crew Impact Award, recognizing her dedication to leading with heart, serving with purpose and uplifting everyone around her in the Pink Bubble.